We are live on
!
Find out more
SC
Samlyn Capital Portfolio holdings
AUM
$6.14B
1-Year Est. Return
42.05%
This Fund
S&P 500
This Quarter
Est. Return
+1.53%
1 Year Est. Return
+42.05%
3 Year Est. Return
+148.08%
5 Year Est. Return
+210.34%
10 Year Est. Return
+1,110.53%
AUM
$4.19B
AUM Growth
-$467M
(-10%)
Cap. Flow
-$654M
Cap. Flow
% of AUM
-15.61%
Top 10 Holdings %
Top 10 Hldgs %
30.64%
Holding
140
New
55
Increased
21
Reduced
30
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$61.5M |
| 2 |
Ulta Beauty
ULTA
|
+$58.8M |
| 3 |
AGN
Allergan plc
AGN
|
+$51.8M |
| 4 |
EA
Electronic Arts
EA
|
+$51.1M |
| 5 |
HCA Healthcare
HCA
|
+$50.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KeyCorp
KEY
|
+$123M |
| 2 |
Regions Financial
RF
|
+$105M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$105M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$84M |
| 5 |
CMA
Comerica
CMA
|
+$77.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.31% |
| 2 | Consumer Discretionary | 16.64% |
| 3 | Financials | 14.59% |
| 4 | Technology | 9.5% |
| 5 | Industrials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
PUT
Corning
GLW
$133B
| – | – |
-1,200,000
| Closed | -$25.1M |
|
|
127
Alphabet (Google) Class C
GOOG
$4.1T
| – | – |
-2,255,920
| Closed | -$84M |
|
|
HBI
128
DELISTED
Hanesbrands
HBI
| – | – |
-860,730
| Closed | -$24.4M |
|
|
KW
129
DELISTED
Kennedy-Wilson Holdings
KW
| – | – |
-623,425
| Closed | -$13.7M |
|
130
LPL Financial
LPLA
$28.3B
| – | – |
-317,200
| Closed | -$7.87M |
|
131
MetLife
MET
$62B
| – | – |
-631,349
| Closed | -$24.7M |
|
132
Pfizer
PFE
$162B
| – | – |
-2,657,374
| Closed | -$74.7M |
|
|
133
Regions Financial
RF
$25.9B
| – | – |
-11,611,786
| Closed | -$105M |
|
134
Synchrony
SYF
$26B
| – | – |
-2,106,600
| Closed | -$60.4M |
|
|
135
Teva Pharmaceuticals
TEVA
$42.4B
| – | – |
-1,954,175
| Closed | -$105M |
|
136
Thermo Fisher Scientific
TMO
$227B
| – | – |
-157,000
| Closed | -$22.2M |
|
|
WBA
137
DELISTED
Walgreens Boots Alliance
WBA
| – | – |
-892,681
| Closed | -$75.2M |
|
138
Williams Companies
WMB
$90.7B
| – | – |
-1,413,000
| Closed | -$22.7M |
|
|
BEAV
139
DELISTED
B/E Aerospace Inc
BEAV
| – | – |
-576,000
| Closed | -$26.6M |
|
|
BXLT
140
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| – | – |
-917,900
| Closed | -$37.1M |
|
Similar funds
MF
LP
SLI
MSU
EQF
PAMP
WCM
MOS
Samlyn Capital's Q2 2016 Portfolio in Review
As of Q2 2016, Samlyn Capital held 140 positions worth $4.19B, down 10% from $4.66B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Samlyn Capital withdrew a net $654M in Q2 2016, closing 30 positions and reducing 30 holdings. Its most notable exit was Regions Financial, an estimated $105M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Samlyn Capital opened a new position in Ulta Beauty worth $65.8M.
- Samlyn Capital's largest Q2 2016 buy was Ulta Beauty: 270,205 shares worth $65.8M.
- Samlyn Capital added most to Biogen in Q2 2016, an estimated $61.5M increase.
- Samlyn Capital's biggest Q2 2016 reduction was KeyCorp, cutting an estimated $123M.
- Samlyn Capital fully exited Regions Financial in Q2 2016, selling an estimated $105M.
- Samlyn Capital's ten largest holdings make up 31% of its $4.19B portfolio in Q2 2016.
- Samlyn Capital opened 55 new positions and closed 30 in Q2 2016.
- Samlyn Capital's portfolio value fell 10% quarter-over-quarter to $4.19B.
Based on Samlyn Capital's 13F filing for Q2 2016, filed 15 Aug 2016.